Marianna Sirico

ORCID: 0000-0002-2536-3858 · 4 papers in corpus
2025
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study
·doi:10.1016/j.ijgc.2024.100369
2025
Hormonal Therapy In Endometriosis And Breast Cancer Risk: A Propensity Score-Matched Real-World Analysis
·doi:10.1016/j.ijgc.2024.101267
observational 2025
Real-world assessment of breast cancer risk following hormonal therapy in endometriosis: A Global Collaborative Network propensity score matched analysis.
·doi:10.1200/jco.2025.43.16_suppl.11143

11143 Background: Research suggests endometriosis, an estrogen-dependent condition, may be a potential risk factor for breast cancer (BC) development. While oral contraceptives are the standard treatment, their efficacy is limited in sympto…

review 2024
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review
BMJ oncology ·doi:10.1136/bmjonc-2024-000330

Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk factors and a limited adher…